Sandbox:meital

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 5: Line 5:
-->
-->
-
<Structure load='2nmz' size='300' frame='true' align='right' caption='Insert caption here' scene='' Saquinavir (SQV), the first antiviral HIV-1 protease (PR) inhibitor approved for AIDS therapy, has been studied in complexes with PR and the variants PR(I) (84V) and PR(V) (82A) containing the single mutations I84V and V82A that provide resistance to all... [ Read More & Search PubMed Abstracts ] />
+
<Structure load='2nmz' size='300' frame='true' align='right' caption='Saquinavir (SQV), the first antiviral HIV-1 protease (PR) inhibitor approved for AIDS therapy, has been studied in complexes with PR and the variants PR(I) (84V) and PR(V) (82A) containing the single mutations I84V and V82A that provide resistance to all... [ Read More & Search PubMed Abstracts ] ' scene=''

Revision as of 11:04, 10 July 2011


<Structure load='2nmz' size='300' frame='true' align='right' caption='Saquinavir (SQV), the first antiviral HIV-1 protease (PR) inhibitor approved for AIDS therapy, has been studied in complexes with PR and the variants PR(I) (84V) and PR(V) (82A) containing the single mutations I84V and V82A that provide resistance to all... [ Read More & Search PubMed Abstracts ] ' scene=

Personal tools